Anti-HIV derivatives of 1-(2,3-dideoxy-3-n-hydroxyamino-β-d-thre o-pentofu ranosyl) thymine

Jean M.T. Tronchet, Martina Zsely, Karel Capek, Istvan Komaromi, Michel Geoffroy, Erik De Clercq, Jan Balzarini

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Representative examples of the title compounds including bicyclic analogs (7–9) in which a perhydro-l,3-oxazine is ortho-iused to the furanose ring, have been prepared in good to excellent yields. Compounds 5 and 7 showed marked activity against HTV-1 and HTV-2 replication in CEM cells (50% inhibitory concentration: 0.80-4.3(ig/mL). Their di-O-acetylated (6) and mono-O-acetylated (8) derivatives were considerably less effective. To the best of our knowledge, these fi-D-threo anti-HIV nucleoside analogs constitute the first examples of anti-HTV active nucleosides bearing this configuration.

Original languageEnglish
Pages (from-to)1871-1889
Number of pages19
JournalNucleosides and Nucleotides
Volume13
Issue number9
DOIs
Publication statusPublished - Sep 1 1994

ASJC Scopus subject areas

  • Biochemistry
  • Genetics

Fingerprint Dive into the research topics of 'Anti-HIV derivatives of 1-(2,3-dideoxy-3-n-hydroxyamino-β-d-thre o-pentofu ranosyl) thymine'. Together they form a unique fingerprint.

  • Cite this

    Tronchet, J. M. T., Zsely, M., Capek, K., Komaromi, I., Geoffroy, M., Clercq, E. D., & Balzarini, J. (1994). Anti-HIV derivatives of 1-(2,3-dideoxy-3-n-hydroxyamino-β-d-thre o-pentofu ranosyl) thymine. Nucleosides and Nucleotides, 13(9), 1871-1889. https://doi.org/10.1080/15257779408010670